Enoxaparin is commonly used for prophylaxis as an anticoagulant in hospital settings. Although enoxaparin has been known to cause many minor adverse reactions, hepatocellular injury is one of the rare side effects which can impact clinical course, marked by an asymptomatic rise in liver function panel tests. In this paper, we not only delineate the relationship between enoxaparin-induced hepatocellular injury but also associate it with fevers that have not been previously documented. Furthermore, we posit the Moderna COVID19 vaccine as a potential contributor to this outcome. We hypothesize that the link between enoxaparin and hepatic injury is possibly due to the inflammatory state, which may be augmented by the vaccine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090673PMC
http://dx.doi.org/10.7759/cureus.24018DOI Listing

Publication Analysis

Top Keywords

hepatocellular injury
8
potential role
4
role moderna
4
moderna covid-19
4
covid-19 vaccine
4
vaccine enoxaparin's
4
enoxaparin's effects
4
effects liver
4
liver functions
4
functions enoxaparin
4

Similar Publications

MicroRNAs (miRNAs) have been recognised as potential biomarkers due to their specific expression patterns in different biological tissues and their changes in expression under pathological conditions. MicroRNA-122 (miR-122) is a vertebrate-specific miRNA that is predominantly expressed in the liver and plays an important role in liver metabolism and development. Dysregulation of miR-122 expression is associated with several liver-related diseases, including hepatocellular carcinoma and drug-induced liver injury (DILI).

View Article and Find Full Text PDF

Loss of hepatocyte Usp53 protects mice from a form of xenobiotic-induced liver injury.

Biochim Biophys Acta Mol Basis Dis

December 2024

The Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China; Shanghai Key Laboratory of Birth Defect, Shanghai 201102, China. Electronic address:

Background: Ubiquitin-specific protease 53 (USP53) deficiency is associated with familial intrahepatic cholestasis in which serum gamma-glutamyl transferase (GGT) activity is relatively low. However, how USP53 deficiency contributes to cholestasis is obscure. No animal model has been reported.

View Article and Find Full Text PDF

Advances in the treatment of liver injury based on mesenchymal stem cell-derived exosomes.

Stem Cell Res Ther

December 2024

Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an, 710000, China.

Article Synopsis
  • * MSC-derived exosomes (MSC-EXOs) play a crucial role in addressing various liver conditions like fibrosis, failure, and oxidative stress.
  • * Recent research highlights the formation, function, and characteristics of MSC-EXOs, underscoring their importance in liver regeneration.
View Article and Find Full Text PDF

Effect of SARS-CoV-2 infection on liver function in patients with hepatitis B.

BMC Infect Dis

December 2024

Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou, Medical University, 150 Ximen Road, Linhai, Taizhou, 317000, Zhejiang Province, China.

Objective: To investigate the impact of SARS-CoV-2 infection on liver function and prognosis in patients with HBV infection.

Methods: A total of 154 HBV-positive patients (HBV ( +) group) and 154 HBV-negative patients (HBV (-) group) diagnosed with COVID-19 at Taizhou Hospital between December 10, 2022, and January 31, 2023, were included in this study. Clinical characteristics, treatment, and laboratory findings were collected from patients at three time points: before (T1), during (T2), and at the time of discharge (T3) from SARS-CoV-2 infection.

View Article and Find Full Text PDF

Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death.

Int J Mol Sci

December 2024

Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.

The activation of hypoxia-inducible factors (HIF)-1α and 2α in the liver is closely linked to the progression of fatty liver diseases. Prior studies indicated that disrupting hepatocyte HIF-2α attenuates diet-induced hepatic steatosis, subsequently decreasing fibrosis. However, the direct role of hepatocyte HIF-2α in liver fibrosis has not been addressed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!